Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


Articles published in Chest

Retrieve available abstracts of 98 articles:
HTML format
Text format



Single Articles


    June 2017
  1. BEL EH, Ten Brinke A
    New Anti-Eosinophil Drugs for asthma and COPD: targeting the trait!
    Chest. 2017 Jun 2. pii: S0012-3692(17)31022-X. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  2. VAN DER SCHANS J, Aikman B, de Vries TW, Hoekstra PJ, et al
    Association Between Attention-Deficit/Hyperactivity Disorder and Asthma Among Adults: A Case-Control Study.
    Chest. 2017;151:1406-1407.
    PubMed     Text format    


  3. CHALMERS JD
    Bronchiectasis and COPD Overlap: A Case of Mistaken Identity?
    Chest. 2017;151:1204-1206.
    PubMed     Text format    


    May 2017
  4. BEDI P, Chalmers JD, Graham C, Clarke A, et al
    A randomised control trial of atorvastatin in bronchiectasis patients infected with Pseudomonas aeruginosa- a proof of concept study.
    Chest. 2017 May 26. pii: S0012-3692(17)30966-2. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  5. HENKLE E, Aksamit TR, Barker AF, Curtis JR, et al
    Pharmacotherapy for non-cystic fibrosis bronchiectasis: results from an NTM Info & Research patient survey and the Bronchiectasis and NTM Research Registry.
    Chest. 2017 May 4. pii: S0012-3692(17)30810-3. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  6. MCSHANE PJ
    Bronchiectasis: An Orphan Finds a Home.
    Chest. 2017;151:953-954.
    PubMed     Text format    


    April 2017
  7. CHATTERJEE K, Goyal A, Joshi M
    Thirty-Day Readmissions in Adults Hospitalized for COPD or Bronchiectasis: Findings From the Nationwide Readmission Database 2013.
    Chest. 2017;151:943-945.
    PubMed     Text format    


  8. TOKMAN S, Smith MA, Hashimi AS, Omar A, et al
    A 46-Year-Old Man With Dyspnea, Hypoxemia, and Radiographic Asymmetry After Redo Bilateral Lung Transplantation.
    Chest. 2017;151:e91-e94.
    PubMed     Text format     Abstract available


  9. CHANG AB, Oppenheimer JJ, Weinberger MM, Rubin BK, et al
    Management of Children With Chronic Wet Cough and Protracted Bacterial Bronchitis: CHEST Guideline and Expert Panel Report.
    Chest. 2017;151:884-890.
    PubMed     Text format     Abstract available


  10. JAROSCH I, Gloeckl R, Damm E, Schwedhelm AL, et al
    Short-term Effects of Supplemental Oxygen on 6-Min Walk Test Outcomes in Patients With COPD: A Randomized, Placebo-Controlled, Single-blind, Crossover Trial.
    Chest. 2017;151:795-803.
    PubMed     Text format     Abstract available


    March 2017
  11. MIZUNO S, Ishizaki T, Kadowaki M, Akai M, et al
    p53 signaling pathway polymorphisms associated with emphysematous changes in COPD patients.
    Chest. 2017 Mar 14. pii: S0012-3692(17)30377-X. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  12. HUNT EB, Ward C, Power S, Sullivan A, et al
    The potential role of aspiration in the asthmatic airway.
    Chest. 2017 Mar 11. pii: S0012-3692(17)30365-3. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available



  13. Correction to Figures in: Omalizumab Treatment Response in a Population With Severe Allergic Asthma and Overlapping COPD.
    Chest. 2017;151:730.
    PubMed     Text format    


  14. NISHIHARA T, Nakano H, Nogami H, Katahira K, et al
    A 63-Year-Old Woman With Progressive Dyspnea After Remission of Lymphoma.
    Chest. 2017;151:e57-e62.
    PubMed     Text format     Abstract available


  15. YANG L, Cheriyan J, Gutterman DD, Mayer RJ, et al
    Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers.
    Chest. 2017;151:555-563.
    PubMed     Text format     Abstract available


  16. JENKINS CR, Chapman KR, Donohue JF, Roche N, et al
    Improving the Management of COPD in Women.
    Chest. 2017;151:686-696.
    PubMed     Text format     Abstract available


  17. UPHAM JW, Xi Y
    Dendritic Cells in Human Lung Disease: Recent Advances.
    Chest. 2017;151:668-673.
    PubMed     Text format     Abstract available


    February 2017
  18. DRAIKIWICZ S, Oppenheimer J
    Use of Biological Agents in Asthma: Pharmacoeconomic Lessons Learned From Omalizumab.
    Chest. 2017;151:249-251.
    PubMed     Text format    


  19. MARTINEZ FJ, Rabe KF, Ferguson GT, Fabbri LM, et al
    Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD.
    Chest. 2017;151:340-357.
    PubMed     Text format     Abstract available


  20. BOULET LP, Turmel J, Irwin RS
    Cough in the Athlete: CHEST Guideline and Expert Panel Report.
    Chest. 2017;151:441-454.
    PubMed     Text format     Abstract available


  21. COUILLARD S, Larivee P, Courteau J, Vanasse A, et al
    Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
    Chest. 2017;151:366-373.
    PubMed     Text format     Abstract available


  22. SHETH JS, Belperio JA, Fishbein MC, Kazerooni EA, et al
    Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease.
    Chest. 2017;151:389-399.
    PubMed     Text format     Abstract available


  23. HOLLANDER Z, DeMarco ML, Sadatsafavi M, McManus BM, et al
    Biomarker Development in COPD: Moving From P Values to Products to Impact Patient Care.
    Chest. 2017;151:455-467.
    PubMed     Text format     Abstract available


  24. USSAVARUNGSI K, Kern RM, Roden AC, Ryu JH, et al
    Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Disease: Retrospective Analysis of 74 Cases.
    Chest. 2017;151:400-408.
    PubMed     Text format     Abstract available


    January 2017
  25. SALTER BM, Sehmi R
    Hematopoietic Processes in Eosinophilic Asthma.
    Chest. 2017 Jan 24. pii: S0012-3692(17)30039-9. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  26. DE SOYZA A, McDonnell MJ, Goeminne PC, Aliberti S, et al
    Bronchiectasis Rheumatoid overlap syndrome (BROS) is an independent risk factor for mortality in patients with bronchiectasis: A multicentre cohort study.
    Chest. 2017 Jan 13. pii: S0012-3692(17)30009-0. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  27. STOLZ D, Leeming DJ, Kristensen JH, Karsdal MA, et al
    Systemic Biomarkers of Collagen and Elastin Turnover Are Associated With Clinically Relevant Outcomes in COPD.
    Chest. 2017;151:47-59.
    PubMed     Text format     Abstract available


  28. LAMBERT AA, Putcha N, Drummond MB, Boriek AM, et al
    Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD.
    Chest. 2017;151:68-77.
    PubMed     Text format     Abstract available


  29. SUISSA S, Dell'Aniello S, Ernst P
    Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study.
    Chest. 2017;151:60-67.
    PubMed     Text format     Abstract available


  30. RUSH B, Hertz P, Bond A, McDermid RC, et al
    Use of Palliative Care in Patients With End-Stage COPD and Receiving Home Oxygen: National Trends and Barriers to Care in the United States.
    Chest. 2017;151:41-46.
    PubMed     Text format     Abstract available


    December 2016
  31. LO CASCIO CM, Quante M, Hoffman EA, Bertoni AG, et al
    Percent emphysema and daily motor activity levels in the general population: Multi-Ethnic Study of Atherosclerosis.
    Chest. 2016 Dec 6. pii: S0012-3692(16)62561-8. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  32. THAKUR N, Barcelo NE, Borrell LN, Singh S, et al
    Perceived Discrimination Associated with Asthma and Related Outcomes in Minority Youth: The GALA II and SAGE II Studies.
    Chest. 2016 Dec 1. pii: S0012-3692(16)62550-3. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


    November 2016
  33. DIAZ AA, Young TP, Maselli DJ, Martinez CH, et al
    Quantitative CT measures of bronchiectasis in smokers.
    Chest. 2016 Nov 24. pii: S0012-3692(16)62460-1. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  34. AKSAMIT TR, O'Donnell AE, Barker A, Olivier KN, et al
    Adult Bronchiectasis Patients: A First Look at the United States Bronchiectasis Research Registry.
    Chest. 2016 Nov 23. pii: S0012-3692(16)62354-1. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  35. ALCAIDE AB, Sanchez P, Bastarrika G, Campo A, et al
    Clinical Features of Smokers with Radiological Emphysema but without Airway Limitation.
    Chest. 2016 Nov 3. pii: S0012-3692(16)62332-2. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  36. MOLDAVER DM, Larche M, Rudulier CD
    An update on lymphocyte subtypes in Asthma and Airway Disease.
    Chest. 2016 Nov 3. pii: S0012-3692(16)62326-7. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  37. MITCHELL PD, O'Byrne PM
    Epithelial Derived Cytokines in Asthma.
    Chest. 2016 Nov 3. pii: S0012-3692(16)62330-9. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  38. SADATSAFAVI M, Tavakoli H, Lynd L, FitzGerald JM, et al
    Has asthma medication use caught up with the evidence? A 12-year population-based study of trends.
    Chest. 2016 Nov 1. pii: S0012-3692(16)62294-8. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  39. VEERANKI SP, Sharma K, Ohabughiro MU, Mehta HB, et al
    30-Day Readmissions in Hospitalized Adults With Asthma Exacerbations: Insights From the Nationwide Readmission Database.
    Chest. 2016;150:1162-1165.
    PubMed     Text format    


    October 2016
  40. KELLY RS, Dahlin A, McGeachie MJ, Qiu W, et al
    Asthma metabolomics and the potential for integrative omics in research and the clinic.
    Chest. 2016 Oct 21. pii: S0012-3692(16)60777-8. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  41. MALTBY S, Gibson PG, Powell H, McDonald VM, et al
    Omalizumab Treatment Response in a Severe Allergic Asthma Population with Overlapping COPD.
    Chest. 2016 Oct 11. pii: S0012-3692(16)60754-7. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  42. LUYSTER FS, Strollo PJ Jr, Holguin F, Castro M, et al
    Association between insomnia and asthma burden in the Severe Asthma Research Program (SARP) III.
    Chest. 2016 Oct 6. pii: S0012-3692(16)59338-6. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  43. EVANS IE, Bedi P, Quinn TM, Hill AT, et al
    Bronchiectasis severity is an independent risk factor for vascular disease in a Bronchiectasis Cohort.
    Chest. 2016 Oct 6. pii: S0012-3692(16)59340-4. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  44. BARNES PJ
    COUNTERPOINT: Will new anti-eosinophilic drugs be useful in asthma management? No.
    Chest. 2016 Oct 6. pii: S0012-3692(16)59341-6. doi: 10.1016/j.chest.2016.
    PubMed     Text format    


  45. O'BYRNE PM
    POINT: Will New Anti-eosinophilic Drugs Be Useful In Asthma Management: Yes.
    Chest. 2016 Oct 6. pii: S0012-3692(16)59339-8. doi: 10.1016/j.chest.2016.
    PubMed     Text format    


  46. RUSSELL R, Brightling CE
    Anti-IL-5 for Severe Asthma: Aiming High to Achieve Success.
    Chest. 2016;150:766-768.
    PubMed     Text format    


    September 2016
  47. NAIR P, O'Byrne PM
    Measuring Eosinophils to Make Treatment Decisions in Asthma.
    Chest. 2016;150:485-7.
    PubMed     Text format    


    August 2016
  48. HILL AT
    Macrolides for Clinically Significant Bronchiectasis in Adults: Who Should Receive this Treatment?
    Chest. 2016 Aug 31. pii: S0012-3692(16)58873.
    PubMed     Text format     Abstract available


  49. ALEVA FE, Voets LW, Simons SO, de Mast Q, et al
    Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A systematic review and meta-analysis.
    Chest. 2016 Aug 11. pii: S0012-3692(16)53752-0. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  50. BENFANTE A, Battaglia S, Scichilone N
    Serum Surfactant Protein D as a Marker of Asthma Severity.
    Chest. 2016;150:473-4.
    PubMed     Text format    


  51. TAKIR HB, Esquinas A
    Hospitals' Patterns of Noninvasive Ventilation in Asthma: Evidence or Deep Recommendations Needed?
    Chest. 2016;150:468-9.
    PubMed     Text format    


    July 2016
  52. GOTZEV S, Lipszyc JC, Connor D, Tarlo SM, et al
    Trends in Occupations and Work Sectors among Work-Related Asthma Patients at a Canadian Tertiary Care Clinic.
    Chest. 2016 Jul 18. pii: S0012-3692(16)52656-7. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  53. WURZEL DF, Marchant JM, Yerkovich ST, Upham JW, et al
    Protracted Bacterial Bronchitis in Children: Natural History and Risk Factors for Bronchiectasis.
    Chest. 2016 Jul 8. pii: S0012-3692(16)52591-4. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  54. WEINBERGER M
    Counterpoint: Is escalation of the inhaled corticosteroid dose appropriate for acute loss of asthma control in an attempt to reduce need for oral corticosteroids in children? No.
    Chest. 2016 Jul 4. pii: S0012-3692(16)52529-X. doi: 10.1016/j.chest.2016.
    PubMed     Text format    


  55. FARBER HJ
    Point: Is escalation of the inhaled corticosteroid dose appropriate for acute loss of asthma control in an attempt to reduce need for oral corticosteroids in children? Yes.
    Chest. 2016 Jul 4. pii: S0012-3692(16)52527-6. doi: 10.1016/j.chest.2016.
    PubMed     Text format    


  56. COSIO BG, Shafiek H, Iglesias A, Yanez A, et al
    Oral Low-dose Theophylline on Top of Inhaled Fluticasone-Salmeterol Does Not Reduce Exacerbations in Patients With Severe COPD: A Pilot Clinical Trial.
    Chest. 2016;150:123-30.
    PubMed     Text format     Abstract available


  57. YOHANNES AM, Dryden S, Hanania NA
    The Responsiveness of the Anxiety Inventory for Respiratory Disease Scale Following Pulmonary Rehabilitation.
    Chest. 2016;150:188-95.
    PubMed     Text format     Abstract available


    June 2016
  58. YAO X, Gordon EM, Barochia AV, Remaley AT, et al
    The A's have it: Developing Apolipoprotein A-I Mimetic Peptides into a Novel Treatment for Asthma.
    Chest. 2016 Jun 17. pii: S0012-3692(16)50294-3. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  59. CHAHLA M, Larson CD, Parekh KR, Reed RM, et al
    Transpleural Ventilation via Spiracles in Severe Emphysema Increases Alveolar Ventilation.
    Chest. 2016;149:e161-7.
    PubMed     Text format     Abstract available


  60. ALDRICH TK, Vossbrinck M, Zeig-Owens R, Hall CB, et al
    Lung Function Trajectories in World Trade Center-Exposed New York City Firefighters Over 13 Years: The Roles of Smoking and Smoking Cessation.
    Chest. 2016;149:1419-27.
    PubMed     Text format     Abstract available


    May 2016
  61. VERLEDEN SE, Sacreas A, Vos R, Vanaudenaerde BM, et al
    Advances in Understanding Bronchiolitis Obliterans after lung transplantation.
    Chest. 2016 May 19. pii: S0012-3692(16)48564-8. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  62. MITCHELL PD, O'Byrne PM
    Surfactant Protein-D and Asthma.
    Chest. 2016;149:1121-2.
    PubMed     Text format    


  63. CALZETTA L, Rogliani P, Matera MG, Cazzola M, et al
    A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD.
    Chest. 2016;149:1181-96.
    PubMed     Text format     Abstract available


  64. MEHARI A, Klings ES
    Chronic Pulmonary Complications of Sickle Cell Disease.
    Chest. 2016;149:1313-24.
    PubMed     Text format     Abstract available


  65. MUMMADI SR, Hahn PY
    Update on Exhaled Nitric Oxide in Clinical Practice.
    Chest. 2016;149:1340-4.
    PubMed     Text format     Abstract available


  66. TAIVASSALO T, Hussain SN
    Contribution of the Mitochondria to Locomotor Muscle Dysfunction in Patients With COPD.
    Chest. 2016;149:1302-12.
    PubMed     Text format     Abstract available


  67. WELLS JM, Morrison JB, Bhatt SP, Nath H, et al
    Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD.
    Chest. 2016;149:1197-204.
    PubMed     Text format     Abstract available


    April 2016
  68. HASEGAWA K, Tsugawa Y, Clark S, Eastin CD, et al
    Improving Quality of Acute Asthma Care in U.S. Hospitals: Changes between 1999-2000 and 2012-2013.
    Chest. 2016 Apr 4. pii: S0012-3692(16)47556-2. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  69. KAPLAN D, Rondina MT
    Response.
    Chest. 2016;149:1107-8.
    PubMed     Text format    


  70. FARBER HJ
    Response.
    Chest. 2016;149:1106-7.
    PubMed     Text format    


  71. NGUYEN DV, Murin S
    Bronchial Artery Pseudoaneurysm With Major Hemorrhage After Bronchial Thermoplasty.
    Chest. 2016;149:e95-7.
    PubMed     Text format     Abstract available


  72. YOHANNES AM, Leroi I
    Treat the Brain to Improve the Lungs?: Mental Illness as a Risk Factor for Readmission in COPD.
    Chest. 2016;149:887-8.
    PubMed     Text format    


  73. YOHANNES AM, Mullerova H, Hanania NA, Lavoie K, et al
    Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort.
    Chest. 2016;149:916-26.
    PubMed     Text format     Abstract available


  74. YI F, Chen R, Luo W, Xu D, et al
    Validity of Fractional Exhaled Nitric Oxide in Diagnosis of Corticosteroid-Responsive Cough.
    Chest. 2016;149:1042-51.
    PubMed     Text format     Abstract available


  75. HODGSON D, Anderson J, Reynolds C, Oborne J, et al
    The Effects of Azithromycin in Treatment-Resistant Cough: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Chest. 2016;149:1052-60.
    PubMed     Text format     Abstract available


  76. MARTINEZ CH, Diaz AA, Parulekar AD, Rennard SI, et al
    Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts.
    Chest. 2016;149:927-35.
    PubMed     Text format     Abstract available


    March 2016
  77. MARSDEN PA, Satia I, Ibrahim B, Woodcock A, et al
    Objective Cough Frequency, Airway Inflammation and Disease Control in Asthma.
    Chest. 2016 Mar 10. pii: S0012-3692(16)41619-3. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  78. FIORE MC, Jorenby DE, Baker TB
    Don't Wait for COPD to Treat Tobacco Use.
    Chest. 2016;149:617-8.
    PubMed     Text format    


  79. PRADERE P, Gauvain C, Danel C, Debray MP, et al
    Airway-Centered Fibroelastosis: A Distinct Entity.
    Chest. 2016;149:767-74.
    PubMed     Text format     Abstract available


  80. SCHAUER GL, Wheaton AG, Malarcher AM, Croft JB, et al
    Health-care Provider Screening and Advice for Smoking Cessation Among Smokers With and Without COPD: 2009-2010 National Adult Tobacco Survey.
    Chest. 2016;149:676-84.
    PubMed     Text format     Abstract available


  81. PAPAKONSTANTINOU E, Klagas I, Roth M, Tamm M, et al
    Acute Exacerbations of COPD Are Associated With Increased Expression of Heparan Sulfate and Chondroitin Sulfate in BAL.
    Chest. 2016;149:685-95.
    PubMed     Text format     Abstract available


  82. BEAUCHAMP MK, Harrison SL, Goldstein RS, Brooks D, et al
    Interpretability of Change Scores in Measures of Balance in People With COPD.
    Chest. 2016;149:696-703.
    PubMed     Text format     Abstract available


    February 2016
  83. ROSAS-SALAZAR C, Han YY, Brehm JM, Forno E, et al
    Gun violence, African ancestry, and asthma: a case-control study in Puerto Rican children.
    Chest. 2016 Feb 18. pii: S0012-3692(16)01258-7. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  84. WAN WH, Hollins F, Haste L, Woodman L, et al
    NADPH oxidase 4 over-expression is associated with epithelial ciliary dysfunction in neutrophilic asthma.
    Chest. 2016 Feb 2. pii: S0012-3692(16)00518-3. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  85. CHRISTOPHER KL, Repine JE
    Rebuttal From Drs Christopher and Repine.
    Chest. 2016;149:309-10.
    PubMed     Text format    


  86. KOPP VJ, Stavas JM
    Rebuttal From Drs Kopp and Stavas.
    Chest. 2016;149:308-9.
    PubMed     Text format    


  87. CHRISTOPHER KL, Repine JE
    COUNTERPOINT: Does Low-Dose Oxygen Expose Patients With COPD to More Radiation-Like Risks Than Patients Without COPD? No.
    Chest. 2016;149:306-8.
    PubMed     Text format    


  88. KOPP VJ, Stavas JM
    POINT: Does Low-Dose Oxygen Expose Patients With COPD to More Radiation-Like Risks Than Patients Without COPD? Yes.
    Chest. 2016;149:303-6.
    PubMed     Text format    


  89. KARLOH M, Fleig Mayer A, Maurici R, Pizzichini MM, et al
    The COPD Assessment Test: What Do We Know So Far?: A Systematic Review and Meta-Analysis About Clinical Outcomes Prediction and Classification of Patients Into GOLD Stages.
    Chest. 2016;149:413-25.
    PubMed     Text format     Abstract available


  90. ESSER RW, Stoeckel MC, Kirsten A, Watz H, et al
    Structural Brain Changes in Patients With COPD.
    Chest. 2016;149:426-34.
    PubMed     Text format     Abstract available


  91. YOHANNES AM, Raue PJ, Kanellopoulos D, McGovern A, et al
    Predictors of All-Cause Mortality in Patients With Severe COPD and Major Depression Admitted to a Rehabilitation Hospital.
    Chest. 2016;149:467-73.
    PubMed     Text format     Abstract available


  92. LI MH, Fan LC, Mao B, Yang JW, et al
    Short-term Exposure to Ambient Fine Particulate Matter Increases Hospitalizations and Mortality in COPD: A Systematic Review and Meta-analysis.
    Chest. 2016;149:447-58.
    PubMed     Text format     Abstract available


  93. CHENG L, Liu J, Li B, Liu S, et al
    Cigarette Smoke-Induced Hypermethylation of the GCLC Gene Is Associated With COPD.
    Chest. 2016;149:474-82.
    PubMed     Text format     Abstract available


    January 2016
  94. MACKAY RA, Grainge CL, Lau LC, Barber C, et al
    Airway surfactant protein D (SP-D) deficiency in adults with severe asthma.
    Chest. 2016 Jan 13. pii: S0012-3692(15)00177-4. doi: 10.1016/j.chest.2015.
    PubMed     Text format     Abstract available


  95. GODFREY MS, Jankowich MD
    The Vital Capacity Is Vital: Epidemiology and Clinical Significance of the Restrictive Spirometry Pattern.
    Chest. 2016;149:238-51.
    PubMed     Text format     Abstract available


  96. RUTTEN EP, Gopal P, Wouters EF, Franssen FM, et al
    Various Mechanistic Pathways Representing the Aging Process Are Altered in COPD.
    Chest. 2016;149:53-61.
    PubMed     Text format     Abstract available


  97. FOOTITT J, Mallia P, Durham AL, Ho WE, et al
    Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.
    Chest. 2016;149:62-73.
    PubMed     Text format     Abstract available


    October 2015
  98. DE-TORRES JP, Marin JM, Casanova C, Pinto-Plata V, et al
    Identification of COPD patients at high risk for lung cancer mortality using the COPD-LUCSS-DLCO.
    Chest. 2015 Oct 29. doi: 10.1378/chest.15-1868.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: